Library Home  Special Collections Home  Manuscripts Home  Pryor Papers

DAVID HAMPTON PRYOR PAPERS, 1934-2004

Group II, Series 4. Aging and Health Issues (Boxes 202-243 Microfilm Reels 524-555)

• Subseries 1. Aging and Miscellaneous Health Issues
• Subseries 2. Health Care Reform
• Subseries 3. Pharmaceutical Industry and Drug Issues
• Subseries 4. Chronological Files and Library Item Encyclopedias
• Subseries 5. Correspondence–Restricted Materials
• Subseries 6. Oversize Materials

This series contains materials related to aging and health. Subseries 1 includes materials related to Senator Pryor's activities as a member of the Senate Special Committee on Aging as well as materials related to the fraud of the elderly, nursing home reform, and miscellaneous health issues. Subseries 2 includes materials related to Medicaid and Medicare, Social Security, and disability issues. Subseries 3 includes materials discussing federal tax credits for pharmaceutical companies manufacturing drugs in Puerto Rico. Materials in subseries 5 are restricted as per donor agreement. Restricted materials may NOT be accessed.

Subseries 1. Aging and Miscellaneous Health Issues

This subseries contains materials related to Senator Pryor's activities with the Senate Special Committee on Aging. It also contains his voting record on health issues. Major topics include deceptive mailings and fraud of the elderly; seniors and risky bank investments; and nursing home reform. Materials on direct-mail scam groups include information on conservative organizer Richard Viguerie. This subseries also includes materials related to award dinners and receptions as well as miscellaneous topics such as cataract surgery, disease research, fetal tissue research, tobacco, privacy and right-to-know issues, and the White House Conference on Aging. Materials related to drug pricing and the Senate Special Committee on Aging are in subseries 3.

Box 202 Aging and Miscellaneous Health Issues

1. Administration on Aging–Congressional Award Reception, 1994.
2. Age Discrimination in Employment Act–1987.
3. Age Discrimination in Employment Act–1988.
4. Alzheimer's Disease.
5. American Association of Homes for the Aging–1979.
6. American Association of Retired Persons–1992, 1995.
7. American Federation for Clinical Research–1995.
8. American Public Health Association–1989.
9. Brain Disease Research (Alzheimer's, Parkinson's).
10. Cancer Research–1989.
11. Cataract Surgery–1988-1993 (1 of 3).
12. Cataract Surgery–1988-1993 (2 of 3).
13. Cataract Surgery–1988-1993 (3 of 3).
14. Certified Registered Nurse Anesthetists.
15. Child Care Legislation–1988-1989.
16. Clear Cell Sarcoma–1996.
17. Clinton Administration–Breast Cancer Research, 1993.
18. Congress–ACTION.

Committee on Aging

19. 1979, 1986-1990.
20. 1991-1992 (1 of 2), 102nd Congress.
21. 1991-1992 (2 of 2), 102nd Congress.
22. 1993-1994, 103rd Congress.
23. 1995, 104th Congress Workplan.
24. Field Hearing, Long-Term Care, August 1990.
25. Hearing, October 1995.
26. Hearing, November 1995.
27. Investigations, 1989.
28. Legislation, 1989-1991.
29. Legislation, 1991-1992.
30. Miscelleneous.
31. Newsletter–Frankability.
32. Press Activities, Jan 1992-Mar 1993.
33. Press Activities, Jan-Mar 1992, Activities Record and Press Releases.
34. Press Activities, Jan-Mar 1992, Articles.
35. Press Activities, Apr-Jun 1992.
36. Press Activities, Apr-Jun 1992, Articles (1 of 2).

Box 203 Aging and Miscellaneous Health Issues

Committee on Aging

1. Press Activities, Apr-Jun 1992, Articles (2 of 2).
2. Press Activities, Ju1-Dec 1992 (1 of 3).
3. Press Activities, Ju1-Dec 1992 (2 of 3).
4. Press Activities, Ju1-Dec 1992 (3 of 3).
5. Press Activities, Jan-Mar 1993, Activities Record and Press Releases.
6. Press Activities, Jan-Mar 1993, Articles (1 of 2).
7. Press Activities, Jan-Mar 1993, Articles (2 of 2).
8. Press Activities, Apr-Jun 1993.
9. Report of Achievements,1989-1994.
10. Seminar Mailing List, 1990.
11. Staff Materials, 1989-1995.
12. Work Plans, 1989-1991.

Miscellaneous Health Issues

13. Congressional Senior Citizen Intern Program–1992.
14. Charles Cranford.
15. Diabetes–1991.
16. Distinguished Senior Award Dinner–1993.
17. Down's Syndrome.
18. Joycelyn Elders (See Boxes 117 and 132).
19. Family Friends Program.
20. Federal Trade Commission–1995.
21. Fetal Tissue Research.
22. Food and Drug Administration–"Investigational Use of Marketed Products," 1996.

Fraud–Seniors and Deceptive Mailings

23. American Council for Health Care Reform.
24. Bond Sales–Fraudulent, 1990-1991.
25. Citizens Against Rationing Health.
26. Consumer Fraud–1992.
27. Deceptive Mailings–1993.
28. Deceptive Mailings–1993, Oversize Materials (See Box 243).
29. Direct-Mail Scam Groups (1 of 5).
30. Direct-Mail Scam Groups (2 of 5).
31. Direct-Mail Scam Groups (3 of 5).
32. Direct-Mail Scam Groups (4 of 5).
33. Direct-Mail Scam Groups (5 of 5).
34. Fraudulent Mailings–Examples.
35. Health Care Reform–Accuracy of Advertisements.
36. Jim Michie–Investigations.
37. National Committee to Preserve Social Security.
38. Project Cure Inc.
39. Pryor–Speech, Direct-Mail Scam Groups, 1995.
40. Seniors Coalition (1 of 3).
41. Seniors Coalition (2 of 3).
42. Seniors Coalition (3 of 3).
43. Senior Organizations–Fraud.
44. Telemarketing Fraud–1996.

Box 204 Aging and Miscellaneous Health Issues

Fraud--Seniors and Deceptive Mailings

1. USA Inc.
2. Richard Viguerie.

Fraud--Seniors and Risky Bank Investments

3. Bank Sales of Uninsured Products–1994-1995, Hearing (1 of 3).
4. Bank Sales of Uninsured Products–1994-1995, Hearing (2 of 3).
5. Bank Sales of Uninsured Products–1994-1995, Hearing (3 of 3).
6. Bank Sales of Uninsured Products–1994-1995, Investigation (1 of 2).
7. Bank Sales of Uninsured Products–1994-1995, Investigation (2 of 2).
8. Bank Sales of Uninsured Products–1994-1995, Legislation (1 of 2).
9. Bank Sales of Uninsured Products–1994-1995, Legislation (2 of 2).
10. Bank Sales of Uninsured Products–1994-1995, Miscellaneous Materials (1 of 2).
11. Bank Sales of Uninsured Products–1994-1995, Miscellaneous Materials (2 of 2).
12. Bank Sales of Uninsured Products–1994-1995, Miscellaneous Materials, Oversize (See Box 243).
13. Committee on Aging (COA)–Uninsured Bank Products, 1994-1995 (1 of 3).
14. COA–Uninsured Bank Products, 1994-1995 (2 of 3).
15. COA–Uninsured Bank Products, 1994-1995 (3 of 3).

Miscellaneous Health Issues

16. Health Care and Crime–1993.
17. Health Care Quality Alliance–1988.
18. Health Issues–Literature, 1989.
19. Health Management Associates–Mexican Plasma-Phoresis Center, 1986.
20. Hearing Aids–1995.
21. Hearing Proposals–1989.
22. Home Health Care–LPNs, 1988.
23. Infant Formula–1978-1995.
24. Institute for Neurology and Neuroscience Research.
25. Inter-Agency Forum on Aging-Related Statistics–1994.
26. Leadership Council of Aging Organizations.
27. Lou Gehrig's Disease–1993.
28. Mailing List Codes.
29. Medical Herald Controversy–1991.
30. Medical Malpractice–1991 (1 of 2).
31. Medical Malpractice–1991 (2 of 2).
32. Medical Malpractice–1991, American Medical Association.
33. Medical Malpractice–1991, Hatch Medical Liability Reform Act.
34. Medical Malpractice–n.d., Committee on Ways and Means.
35. Medical Privacy–1993.
36. Meeting–Sep 13, 1989.
37. Mental Health–1995-1996.
38. Mental Health Working Group–1994.
39. Mental Health Working Group–1994, Oversized Materials (See Box 243).
40. Mental Retardation–1984.
41. Miscellaneous.
42. National Gerontological Nursing Association–1987.
43. National Association of Nutrition and Aging Services Program–Conference, 1990.
44. National Association of State Long Term Care Ombudsman Programs–1995.
45. National Federation for Specialty Nursing Organizations–1990.

Box 205 Aging and Miscellaneous Health Issues

1. National Health Policy Forum–1989.
2. National Institute for Occupational Safety and Health–1984.
3. National Library of Medical Online Services–Training Policy and Programs.

Nursing Home Reform

4. Board and Care Hearing–1989 (1 of 8).
5. Board and Care Hearing–1989 (2 of 8).
6. Board and Care Hearing–1989 (3 of 8).
7. Board and Care Hearing–1989, (4 of 8).
8. Board and Care Hearing–1989, (5 of 8).
9. Board and Care Hearing–1989, (6 of 8).
10. Board and Care Hearing–1989, (7 of 8).
11. Board and Care Hearing–1989 (8 of 8).
12. Board and Care Hearing–1989, Oversize Materials (See Box 243).
13. California Law Center–Nursing Homes, 1988-1989.
14. Gatekeeper Program–1995.
15. Medigrant Bill–Nursing Home Amendments.
16. National Citizens Coalition for Nursing Home Reform–Oct 1988.
17. Nursing Home Costs–1990.
18. Nursing Home Inspection–1988.
19. Nursing Homes–1991, Chemical Restraints (1 of 3).
20. Nursing Homes–1991, Chemical Restraints (2 of 3).
21. Nursing Homes–1991, Chemical Restraints (3 of 3).
22. Nursing Homes–1991, Chemical Restraints, Oversize Material (See Box 243).
23. Nursing Homes–1993.
24. Nursing Homes–1994, Deemed Status.
25. Nursing Homes–1995 (1 of 7).
26. Nursing Homes–1995 (2 of 7).
27. Nursing Homes–1995 (3 of 7).
28. Nursing Homes–1995 (4 of 7).
29. Nursing Homes–1995 (5 of 7).
30. Nursing Homes–1995 (6 of 7).
31. Nursing Homes–1995 (7 of 7).
32. Nursing Homes–1995, Budget.
33. Nursing Homes–1995, Oversize Material (See Box 243).
34. Nursing Homes–1995, Pryor's Briefing Book.

Box 206 Aging and Miscellaneous Health Issues

Nursing Home Reform

1. Nursing Homes–1995, Republican Plan.
2. Nursing Homes–1995, Standards.
3. Nursing Homes–1995-1996, Enforcement (1 of 3).
4. Nursing Homes–1995-1996, Enforcement (2 of 3).
5. Nursing Homes–1995-1996, Enforcement (3 of 3).
6. Nursing Homes–1996 (1 of 2).
7. Nursing Homes–1996 (2 of 2).
8. Nursing Homes–Inspections (Oversize; see Box 243).
9. Omnibus Budget Reconciliation Act (OBRA)1987.
10. OBRA 1987–Nursing Home Reform Act, 1990 (1 of 2).
11. OBRA 1987–Nursing Home Reform Act, 1990 (2 of 2).
12. OBRA 1987–Nursing Home Reform Act, 1995.
13. Prospective Payment System Bill–1991-1994 (1 of 2).
14. Prospective Payment System Bill–1991-1994 (2 of 2).

Miscellaneous Health Issues

15. Older Americans Month–1994.
16. Patient Outcomes Research Act–1989.
17. Patient Self Determination Act–1989 (1 of 2).
18. Patient Self Determination Act–1989 (2 of 2).
19. David Pryor (DP)–Clippings and Correspondence, 1988-1993
20. DP–Trip to New Hampshire, 1992.
21. DP–Voting Record, 1989-1993
22. DP–Voting Record, 1994.
23. DP–Voting Record, 1995.
24. Public Health–Right-to-Know Act, 1988.
25. Senior Citizens Right to Work Act.
26. Seniors' Organizations–Tax-Exemptions, 1995.
27. Walter Stewart–1993.
28. Tobacco–1988.
29. Tobacco–1992-1996 (1 of 3).
30. Tobacco–1992-1996 (2 of 3).
31. Tobacco–1992-1996 (3 of 3).
32. Eugene J. Towbin–1995.
33. United Seniors Association, Incorporated–Town Meeting, 1993.
34. United Seniors Health Cooperative–Awards Banquet, 1993.
35. White House Conference on Aging–1991, 1993.
36. White House Conference on Aging–1995 (1 of 2).
37. White House Conference on Aging–1995 (2 of 2).

Subseries 2. Health Care Reform

Topics in this subseries include long term care, Medicaid and Medicare, and Social Security and disability issues. Materials related to the Medicaid drug rebate program are in subseries 3.

Box 206 (cont.) Health Care Reform

38. 1987-1990 (1 of 6).

Box 207 Health Care Reform

1. 1987-1990 (2 of 6).
2. 1987-1990 (3 of 6).
3. 1987-1990 (4 of 6).
4. 1987-1990 (5 of 6).
5. 1987-1990 (6 of 6).
6. 1991.
7. 1992 (1 of 2).
8. 1992 (2 of 2).
9. 1993 (1 of 4).
10. 1993 (2 of 4).
11. 1993 (3 of 4).
12. 1993 (4 of 4).
13. 1993, "Health Care . . . in the News Today".
14. 1993, Update.
15. 1993, Working Group Draft (1 of 2).
16. 1993, Working Group Draft (2 of 2).
17. 1993, Workshops.
18. 1994 (1 of 7).
19. 1994 (2 of 7).
20. 1994 (3 of 7).
21. 1994 (4 of 7).
22. 1994 (5 of 7).

Box 208 Health Care Reform

1. 1994 (6 of 7).
2. 1994 (7 of 7).
3. 1994, Dole Plan.
4. 1994, Health Care Reform Briefing Book (1 of 2).
5. 1994, Health Care Reform Briefing Book (2 of 2).
6. 1994, Health Care Reform Project.
7. 1994, Mitchell Bill (1 of 3).
8. 1994, Mitchell Bill (2 of 3).
9. 1994, Mitchell Bill (3 of 3).
10. 1995.
11. 1995, Anti-Trust Legislation.
12. 1996.
13. American Association of Retired People (AARP)–Simpson Hearing (1 of 2).
14. AARP–Simpson Hearing (2 of 2).
15. Better Access to Affordable Health Care Act–1992.
16. COBRA Coalition–1987-1988.
17. Federal Employee Health Benefit–1989.
18. Federal Hospital Insurance Trust Fund–Board of Trustees Report, 1995.
19. Federal Old-Age and Survivors Insurance and Disability Insurance Trust Fund–Board of Trustees Report, 1995.
20. Financial Accounting Standards Board–Post-Retirement Benefits, 1989.
21. Health Care Costs–n.d.
22. Health Insurance Association of America–1988.
23. Health Insurance Availability Act–1987-1988, Risk Pooling.
24. Health Insurance Portability and Accountability Act–1996.
25. Health Span–1986.
26. Health Security Act–1994.
27. Health Security Plan–Briefing Book, 1993.
28. Human Services Reauthorization Act–1995.
29. Insurance Industry–1995.
30. Life Insurance–1983.
31. Long Term Care–1985, 1990.
32. Long Term Care–1991 (1 of 4).
33. Long Term Care–1991 (2 of 4).
34. Long Term Care–1991 (3 of 4).
35. Long Term Care–1991 (4 of 4).
36. Long Term Care–1991, Oversize Materials (See Box 243).
37. Long Term Care–1991-1992 (1 of 3).
38. Long Term Care–1991-1992 (2 of 3).
39. Long Term Care–1991-1992 (3 of 3).
40. Long Term Care–1993, Insurance Consumer Protection Act.
41. Long Term Care–1993-1994.
42. Long Term Care–1994 (1 of 5).

Box 209 Health Care Reform

1. Long Term Care–1994 (2 of 5).
2. Long Term Care–1994 (3 of 5).
3. Long Term Care–1994 (4 of 5).
4. Long Term Care–1994 (5 of 5).
5. Long Term Care–1995 (1 of 3).
6. Long Term Care–1995 (2 of 3).
7. Long Term Care–1995 (3 of 3).
8. Long Term Care–1995, Committee on Aging Hearing.
9. Long Term Care–n.d.
10. Long Term Care–Oversize Materials (See Box 243).
11. Long Term Care–Talking Points.

Medicaid and Medicare

12. Democrats for the 90s–Medicare Study, 1989.
13. Health Insurance Counseling and Assistance Act–1990.
14. Hospitals–Medicaid/Medicare-Dependent, 1990-1992.
15. Medicaid–Children, 1990.
16. Medicaid–State Directors, 1989
17. Medicare–1985, 1989.
18. Medicare–1990-1995.
19. Medicare–Budget, 1991.
20. Medicare–Coverage, 1987-1989.
21. Medicare–In-Patient Psychiatric Services.
22. Medicare–Part B, Balance Billing Limits (1 of 2).
23. Medicare–Part B, Balance Billing Limits (2 of 2).
24. Medicare–Part B, Balance Billing Limits, Oversize Materials (See Box 243).
25. Medicare–n.d.
26. Medicare–Outpatients.
27. Medicare–Regulations.
28. Medicare Beneficiary Protection Amendments–1995.
29. Medicare Catastrophic Coverage Act–1986.
30. Medicare Catastrophic Coverage Act–1987-1988 (1 of 3).
31. Medicare Catastrophic Coverage Act–1987-1988 (2 of 3).
32. Medicare Catastrophic Coverage Act–1987-1988 (3 of 3).
33. Medicare Catastrophic Coverage Act–1987-1988, Oversize Material (See Box 243).

Box 210 Health Care Reform

Medicaid and Medicare

1. Medicare Catastrophic Coverage Act–1988 (1 of 2).
2. Medicare Catastrophic Coverage Act–1988 (2 of 2).
3. Medicare Catastrophic Coverage Act–1989.
4. Medicare Catastrophic Coverage Act–Hearing, June 1989 (1 of 2).
5. Medicare Catastrophic Coverage Act–Hearing, June 1989 (2 of 2).
6. Medicare Geographic Data Accuracy Act–1992.
7. Medicare Health Maintenance Organizations (HMOs)–1994-1996.
8. Medicare HMOs–1994-1996, GAO Report, Draft.
9. Medicare HMOs–1994-1996, GAO Report, Industry Response.
10. Medicare HMOs–1994-1996, GAO Work.
11. Medicare HMOs–1994-1996, Investigation (1 of 2).
12. Medicare HMOs–1994-1996, Investigation (2 of 2).
13. Medigap–Long Term Care, 1990.
14. Murray Scholl–Catastrophic Health Benefits, 1988-1990.
15. Senate Committee on Finance–Hearing, Sep 1995.
16. Senate Committee on Finance–Hearing, Feb 1996.

Health Care Reform

17. Medical Care Quality Research and Improvement Act–1989.
18. Medical Care Savings Account–1992.
19. Medical Equipment and Supplies–Legislation, 1991.
20. Mitchell Home and Community-Based Care Program.
21. Mutual of Omaha–1993.
22. National Institute for Health Care Management.
23. National Leadership Coalition for Health Reform.
24. National Rural Electric Cooperative Association–Retirement Coverage in Smaller Firms, 1988.
25. Older Americans Act–1990.
26. Older Americans Reauthorization Amendments Act–1991.
27. Older Americans Reauthorization Amendments Act–1991, Oversize Material (See Box 243).
28. Older Workers Benefit Protection Act–1990.
29. Patient Advocacy–1989-1991.
30. Pension Complexity–Hearing, March 1990.
31. Pepper Commission–1988-1990 (1 of 3).
32. Pepper Commission–1988-1990 (2 of 3).
33. Pepper Commission–1988-1990 (3 of 3).
34. Pepper Commission–Dec 1989, Meeting.
35. Pepper Commission–1990, Executive Summary.
36. Pepper Commission–1990, Final Report.

Box 211 Health Care Reform

1. Pepper Commission–1990, Final Report Supplement.
2. Primary Care Initiatives Act–1989.
3. Railroad Retirement Act–1981-1985 (1 of 3).
4. Railroad Retirement Act–1981-1985 (2 of 3).
5. Railroad Retirement Act–1981-1985 (3 of 3).
6. Retired Federal Employees Health Benefit Act–1979.
7. Retirement Equity Act–1984-1986 (1 of 4).
8. Retirement Equity Act–1984-1986 (2 of 4).
9. Retirement Equity Act–1984-1986 (3 of 4).
10. Retirement Equity Act–1984-1986 (4 of 4).
11. Retirement Equity Act–1984-1986, Oversize Material (See Box 243).
12. Retirement Health Benefits–1985-1987 (1 of 2).
13. Retirement Health Benefits–1985-1987 (2 of 2).
14. Retirement Health Benefits Preservation Act–1988-1989 (1 of 2).
15. Retirement Health Benefits Preservation Act–1988-1989 (2 of 2).
16. Self-Employed Health Insurance–1991-1992.
17. Self-Employed Health Insurance Act–1993-1995 (1 of 3).
18. Self-Employed Health Insurance Act–1993-1995 (2 of 3).
19. Self-Employed Health Insurance Act–1993-1995 (3 of 3).

Social Security and Disability Issues

20. Americans with Disabilities Act–1990, 1995.
21. APEX–1983.
22. Balanced Budget Amendment–1995.
23. Clippings–1982-1985.
24. Disability Benefits–Investigations, 1987-1989.
25. Disability Programs–Hearing, June 1996.
26. Health and Human Services–Nominations, John A. Svahn and Margaret Heckler, 1983 (1 of 2).
27. Health and Human Services–Nominations, John A. Svahn and Margaret Heckler, 1983 (2 of 2).
28. Pro Bono Program–1989, District of Columbia Bar, Public Services Activities.

Box 212 Health Care Reform

Social Security and Disability Issues
1. Small Business Disabilities Tax Credit Act–1989 (1 of 2).
2. Small Business Disabilities Tax Credit Act–1989 (2 of 2).
3. Social Security–Hearing, Fort Smith, November 1982.
4. Social Security–Disability Amendments, 1980.
5. Social Security Act–1989.
6. Social Security Act Amendments–1994 (Oversize; see Box 243).
7. Social Security and Disability–1989-1995.
8. Social Security and Disability–n.d.
9. Social Security Earnings Test–1995.
10. Social Security Reform–1996 (Oversize; see Box 243).
11. Social Security Reform–Hearing, Sep 1996.
12. Supplemental Security Income (SSI)–1994-1995 (1 of 6).
13. SSI–1994-1995 (2 of 6).
14. SSI–1994-1995 (3 of 6).
15. SSI–1994-1995 (4 of 6).
16. SSI–1994-1995 (5 of 6).
17. SSI–1994-1995 (6 of 6).
18. SSI–1994-1995, Oversize Material (See Box 243).
19. SSI–1995, Children With Disabilities.
20. SSI–1995, Elderly.
21. SSI–1995, Hearing (1 of 2).
22. SSI–1995, Hearing (2 of 2).
23. SSI–1995, Hearing, Oversize Material (See Box 243).
24. SSI–1995, Reports.
25. SSI–1995, Pryor Briefing Book.
26. SSI–1995, Republican Welfare Reform Bill.
27. SSI–1995, Staff Briefing Book (1 of 2).
28. SSI–1995, Staff Briefing Book (2 of 2).
29. SSI–1995, Welfare Reform (1 of 2).
30. SSI–1995, Welfare Reform (2 of 2).

Box 213 Social Security and Disability Issues

1. SSI–1995, Welfare Reform, Testimonies.
2. SSI–1995, Welfare Reform, Titles.
3. SSI–Zebley, Arkansas, Fraud, 1994-1995 (1 of 2).
4. SSI–Zebley, Arkansas, Fraud, 1994-1995 (2 of 2).
5. John White–Nomination, 1993 (Restricted; may not be accessed. Removed to Box 162).

Health Care Reform

6. State Care Act–1992 (1 of 3).
7. State Care Act–1992 (2 of 3).
8. State Care Act–1992 (3 of 3).
9. State Health Care–1992 (1 of 3).
10. State Health Care–1992 (2 of 3).
11. State Health Care–1992 (3 of 3).
12. State Health Care–1992, Arkansas.
13. State Health Care–1992, California/Florida/Vermont.
14. State Health Care–1992, Minnesota (Oversize; see Box 243).
15. State Health Care–1993-1994.
16. State Health Care–1994.
17. Subacute Care–1994-1996.
18. Subacute Care–Conference, 1995 (1 of 2).
19. Subacute Care–Conference, 1995 (2 of 2).
20. Subacute Care–Freestanding Skilled Nursing Facilities, 1994.
21. Subacute Care–Maryland (1 of 2).
22. Subacute Care–Maryland (2 of 2).
23. Subacute Care–Policy Synthesis and Market Area Analysis.
24. Symbols–Misuse of Social Security and Medicare Symbols, 1988.
25. Workfare Development Act–1995.

Subseries 3. Pharmaceutical Industry and Drug Issues

This subseries includes materials relating to the pharmaceutical industry. Topics include the Clinton Administration's health care reform plan; drug pricing; the Medicaid drug rebate program; pharmaceutical patents and the General Agreements on Tariffs and Trade (GATT); and federal tax credits for drug manufacturers based in Puerto Rico. This subseries includes materials related to the National Institutes of Health. It also includes materials related to the treatment of specific diseases, including cancers, Acquired Immune Deficiency Syndrome (AIDS), Alzheimer's Disease, and Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease). Also included are materials relating to the Senate Special Committee on Aging and drug prices.

Box 213 (cont.) Pharmaceutical Industry and Drug Issues

26. Acquired Immune Deficiency Syndrome (AIDS)–1992.
27. AIDS–1993-1995.
28. AIDS–Harvard AZT Study, 1993.
29. Advocacy Groups–1993.
30. Alzheimer's–1990-1993.
31. Alzheimer's–1995.

Box 214 Pharmaceutical Industry and Drug Issues

1. American Association of Retired Persons (AARP)–Pharmacy Services, 1994.
2. AARP–Press Conference, July 1992.
3. American Society of Health-System Pharmacists–1995.
4. Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)–1995.
5. Attention Deficit Disorder.
6. Bayh-Dole Act–1994.
7. Biotechnology–1993-1994.
8. Brain Research–1994-1995.
9. Brain Research–1995 (1 of 2).
10. Brain Research–1995 (2 of 2).
11. Breast Cancer–Tamofixin Citrate.
12. Canada–Patented Medicine Prices Review Board.
13. Cancer Treatments–Laetrile, 1992.
14. Cardene IV (Nicardipine Hydrochloride).
15. Cephalon, Incorporated–1993.
16. Clinton Administration–Health Care Reform Plan, 1992-1994 (1 of 3).
17. Clinton Administration–Health Care Reform Plan, 1992-1994 (2 of 3).
18. Clinton Administration–Health Care Reform Plan, 1992-1994 (3 of 3).
19. Clinton Administration–Health Care Reform Plan, 1992-1994, Oversize Materials (See Box 243).
20. Clinton-Gore Health Care Plan.
21. Committee on Aging (COA)–1989.
22. COA–Hearing, July/November 1989, Prescription Drug Prices.
23. COA–Hearing, April 1992, Drug Costs.
24. COA–Hearing, February 1993, Federal Investment in Drug Research.
25. COA–Hearing, April 1993, Prescription Drug Prices and Older Americans.
26. COA–Staff Reports, 1989-1994.
27. Congressional Research Service (CRS)–Alcohol and Drug Abuse, 1986-1989 (1 of 2).
28. CRS)–Alcohol and Drug Abuse, 1986-1989 (2 of 2).
29. CRS–Drug Control, 1986-1989.
30. CRS–Drug Legalization, 1988.
31. CRS–Drug Testing, 1987-1989.
32. Consumer Price Index–1995.
33. Contraceptives–1989-1991.
34. Cooperative Research and Development Agreements–1992-1995 (1 of 2).
35. Cooperative Research and Development Agreements–1992-1995 (2 of 2).
36. Correspondence–1991-1993.
37. Correspondence–1994 (1 of 2).
38. Correspondence–1994 (2 of 2).
39. Developments in Aging–Prescription Drugs, 1993.
40. Drug Companies–Market Control, 1992-1995 (1 of 2).

Box 215 Pharmaceutical Industry and Drug Issues

1. Drug Companies–Market Control, 1992-1995 (2 of 2).
2. Drug Companies–Market Control, Pryor Statement, 1995.
3. Drug Company Lobbyists.
4. Drug Distribution–1995.
5. Drug Issues–1990 (1 of 5).
6. Drug Issues–1990 (2 of 5).
7. Drug Issues–1990 (3 of 5).
8. Drug Issues–1990 (4 of 5).
9. Drug Issues–1990 (5 of 5).
10. Drug Issues–1994, Oversize Materials (See Box 243).
11. Drug Issues–1995.
12. Drug Marketing–1994 (1 of 2).
13. Drug Marketing–1994 (2 of 2).
14. Drug Price Competition and Patent Term Restoration Act–1996.
15. Drug Pricing–1984, 1989-1990.
16. Drug Pricing–1990-1993, Profit Margins (1 of 2).
17. Drug Pricing–1990-1993, Profit Margins (2 of 2).
18. Drug Pricing–1991-1992.
19. Drug Pricing–1991, CBO Estimate.
20. Drug Pricing–1991, General Accounting Office Report.
21. Drug Pricing–1992.
22. Drug Pricing–1992-1993.
23. Drug Pricing–1992, Hospitals.
24. Drug Pricing–1992-1993, North American Free Trade Agreement.
25. Drug Pricing–1993, National Institutes of Health (NIH) (1 of 4).
26. Drug Pricing–1993, NIH (2 of 4).
27. Drug Pricing–1993, NIH (3 of 4).
28. Drug Pricing–1993, NIH (4 of 4).

Box 216 Pharmaceutical Industry and Drug Issues

1. Drug Pricing–1993-1994 (1 of 10).
2. Drug Pricing–1993-1994 (2 of 10).
3. Drug Pricing–1993-1994 (3 of 10).
4. Drug Pricing–1993-1994 (4 of 10).
5. Drug Pricing–1993-1994 (5 of 10).
6. Drug Pricing–1993-1994 (6 of 10).
7. Drug Pricing–1993-1994 (7 of 10).
8. Drug Pricing–1993-1994 (8 of 10).
9. Drug Pricing–1993-1994 (9 of 10).
10. Drug Pricing–1993-1994 (10 of 10).
11. Drug Pricing–1994.
12. Drug Pricing–1994, Equal Access to Manufacturer Discounts (1 of 5).
13. Drug Pricing–1994, Equal Access to Manufacturer Discounts (2 of 5).
14. Drug Pricing–1994, Equal Access to Manufacturer Discounts (3 of 5).
15. Drug Pricing–1994, Equal Access to Manufacturer Discounts (4 of 5).
16. Drug Pricing–1994, Equal Access to Manufacturer Discounts (5 of 5).
17. Drug Pricing–1994, Equal Access to Manufacturer Discounts, Coalition Material.
18. Drug Pricing–1994, Equal Access to Manufacturer Discounts, Coalition of Health Care Providers.
19. Drug Pricing–1994, Equal Access to Manufacturer Discounts, Opponents.
20. Drug Pricing–1994, Equal Access to Manufacturer Discounts, Robinson-Patman Act.
21. Drug Pricing–1994, Equal Access to Manufacturer Discounts, Vote Count.
22. Drug Pricing–1994, July Hearing.
23. Drug Pricing–1994, Prime Institute Study.
24. Drug Pricing–1995, Lifestyle Magazine Show.
25. Drug Pricing–Charts, 1990-1992.

Box 217 Pharmaceutical Industry and Drug Issues

1. Drug Pricing–Charts, 1993-1994 (1 of 2).
2. Drug Pricing–Charts, 1993-1994 (2 of 2).
3. Drug Pricing–Consumer Price Index, 1996.
4. Drug Pricing–Discriminatory Pricing.
5. Drug Pricing–International Drug Prices, 1994 (1 of 2).
6. Drug Pricing–International Drug Prices, 1994 (2 of 2).
7. Drug Pricing–International Drug Prices, 1994, Dorgan Hearing (1 of 2).
8. Drug Pricing–International Drug Prices, 1994, Dorgan Hearing (2 of 2).
9. Drug Pricing–Maine, 1994.
10. Drug Pricing Rebates–1995.
11. Drug Research–1991-1993, General Accounting Office and Federal Grants.
12. Drug Research–1993 (1 of 3).
13. Drug Research–1993 (2 of 3).
14. Drug Research–1993 (3 of 3).
15. Drug Research–1993, National Institutes of Health.
16. Drug Research–1993, Office of Technology Assessment.
17. Drug Sampling–1993-1994.
18. Drug Treatments–Cost Effectiveness, 1994-1995.
19. Drug Use Review–1992.
20. Drug Utilization Evaluation.
21. DuPont Merck–1993.
22. DuPont Merck–1994.
23. Elderly–Adverse Drug Reaction, 1996 (1 of 5).
24. Elderly–Adverse Drug Reaction, 1996 (2 of 5).
25. Elderly–Adverse Drug Reaction, 1996 (3 of 5).
26. Elderly–Adverse Drug Reaction, 1996 (4 of 5).
27. Elderly–Adverse Drug Reaction, 1996 (5 of 5).
28. Elderly–Prescription Drugs, 1992-1994.
29. Eli Lilly-PCS Merger–1993-1995 (1 of 2).
30. Eli Lilly-PCS Merger–1993-1995 (2 of 2).
31. Emergency Food and Drug Enforcement Act–1990.
32. Equal Access and Drug Pricing Charts–1994.

Box 218 Pharmaceutical Industry and Drug Issues

1. Erythropoietin–1992.
2. Federal Bureau of Investigation–Operation Golden Pill, 1992.
3. Federal Employees Health Benefit Program–1995-1996.
4. Federal Health Programs Pharmaceuticals Fair Pricing Act–1991-1992 (1 of 3).
5. Federal Health Programs Pharmaceuticals Fair Pricing Act–1991-1992 (2 of 3).
6. Federal Health Programs Pharmaceuticals Fair Pricing Act–1991-1992 (3 of 3).
7. Food and Drug Administration (FDA)–1989, 1992.
8. FDA Reform–1995 (1 of 2).
9. FDA Reform–1995 (2 of 2).
10. FDA Reform–1995, Centers for Education and Research in Therapeutics.
11. FDA Reform–1995, Medguide (1 of 2).
12. FDA Reform–1995, Medguide (2 of 2).
13. Federal Supply System–Drug Purchasing 1995.
14. G.D. Searle and Company–1986-1994.
15. General Accounting Office–R&E Credit Study
16. Generic Drugs–1989, Samson/Bass.
17. Generic Drugs–1993-1996.
18. Genzyme Corporation–1993-1995.
19. Glaxo, Incorporated–1993-1995.
20. Group Health Association of America–1990-1993.
21. Calvin Hanna–"Small Drug Companies and the Arkansas Connection," 1989.
22. Health Care Reform–Price Controls and Advisory Council, 1993-1994.
23. Health Care Reform Coalition–Community Retail Pharmacy, 1993.
24. Health Security Act–1994, Biotech Industry.
25. Health Security Act–1994, Drugdex Compendium.
26. Health Security Act–1994, Narrow Therapeutic Drug Amendment.
27. Health Security Act–1994, Radiopharmaceuticals.
28. Health Security Act–1994, Talking Points.
29. Helicobacter Pylori–1994-1995.
30. Hoffmann-LaRoche–1993.
31. Insurance–Administrative Nightmare, 1994.
32. IVAX Corporation–1995.
33. Jack Kay–"The Generic Pharmaceutical Industry: A Canadian Perspective," 1993.
34. Marion Merrell Dow, Incorporated–1994.
35. Medicaid–1990-1992.
36. Medicaid–Conference, November 1994.
37. Medicaid–Health Care Financing Administration, 1993 (1 of 2).
38. Medicaid–Health Care Financing Administration, 1993 (2 of 2).
39. Medicaid–State Drug Formularies, 1993.
40. Medicaid Drug Rebate Program–1991-1993.

Box 219 Pharmaceutical Industry and Drug Issues

1. Medicaid Drug Rebate Program–1992 (1 of 8).
2. Medicaid Drug Rebate Program–1992 (2 of 8).
3. Medicaid Drug Rebate Program–1992 (3 of 8).
4. Medicaid Drug Rebate Program–1992 (4 of 8).
5. Medicaid Drug Rebate Program–1992 (5 of 8).
6. Medicaid Drug Rebate Program–1992 (6 of 8).
7. Medicaid Drug Rebate Program–1992 (7 of 8).
8. Medicaid Drug Rebate Program–1992 (8 of 8).
9. Medicaid Drug Rebate Program–1993-1994.
10. Medicaid Drug Rebate Program–1995, Public Health Service Act.
11. Medicaid Drug Rebate Program–1995-1996 (1 of 4).
12. Medicaid Drug Rebate Program–1995-1996 (2 of 4).
13. Medicaid Drug Rebate Program–1995-1996 (3 of 4).
14. Medicaid Drug Rebate Program–1995-1996 (4 of 4).
15. Medicaid Drug Rebate Program–1996.
16. Medicaid Drug Rebate Program–Briefing Book, 1995.
17. Medicaid Drug Rebate Program–Health and Human Services (HHS) Office of Inspector General, 1991-1993 (1 of 2).
18. Medicaid Drug Rebate Program–HHS Office of Inspector General, 1991-1993 (2 of 2).
19. Medicaid Drug Rebate Program–HHS Office of Inspector General, 1994-1995.
20. Medicaid Drug Rebate Program–HHS Office of Inspector General, Partnership Plan.
21. Medicare–Epogen Reimbursement, 1991-1994 (1 of 2).
22. Medicare–Epogen Reimbursement, 1991-1994 (2 of 2).
23. Medicare Outpatient Prescription Drug Benefit–1994 (1 of 4).
24. Medicare Outpatient Prescription Drug Benefit–1994 (2 of 4).

Box 220 Pharmaceutical Industry and Drug Issues

1. Medicare Outpatient Prescription Drug Benefit–1994 (3 of 4).
2. Medicare Outpatient Prescription Drug Benefit–1994 (4 of 4).
3. Medicare Outpatient Prescription Drug Benefit–1994, Health Security Act.
4. Medicare/Medicaid Amendments Act–1992 (1 of 2).
5. Medicare/Medicaid Amendments Act–1992 (2 of 2).
6. Medicare/Medicaid Technical Amendments–1993 (1 of 2).
7. Medicare/Medicaid Technical Amendments–1993 (2 of 2).
8. Midodrine Hydrochloride.
9. Miscellaneous.
10. Multiple Sclerosis (MS) Home Treatment Equity Act–1994 (1 of 3).
11. MS Home Treatment Equity Act–1994 (2 of 3).
12. MS Home Treatment Equity Act–1994 (3 of 3).
13. National Association of Pharmaceutical Manufacturers–1995.
14. National Association of Retail Druggists (NARD)–103rd Congress, Legislative Issues, 1993-1994.
15. NARD–104th Congress, Legislative Issues, 1995-1996.
16. National Institutes of Health (NIH)–Biomedical Research Funding, 1995.
17. NIH–Drug Fair Price Act, 1993 (1 of 2).
18. NIH–Drug Fair Price Act, 1993 (2 of 2).
19. NIH–Drug Fair Price Act, 1993-1994 (1 of 3).
20. NIH–Drug Fair Price Act, 1993-1994 (2 of 3).
21. NIH–Drug Fair Price Act, 1993-1994 (3 of 3).
22. NIH–Drug Fair Price Act, 1993-1994, Oversize Materials (See Box 243).
23. NIH–Office of Rare Disease Research, 1995.
24. NIH–Recombinant DNA Advisory Committee, 1996.
25. NIH–Task Force on Aging Research, 1994-1995 (1 of 2).
26. NIH–Task Force on Aging Research, 1994-1995 (2 of 2).
27. Notebooks (1 of 3).

Box 221 Pharmaceutical Industry and Drug Issues.

1. Notebooks (2 of 3).
2. Notebooks (3 of 3).
3. Omnibus Budget Reconciliation Act (OBRA)–1990-1993 (1 of 2).
4. OBRA–1990-1993 (2 of 2).
5. Office of Technology Assistance–Residential Care, 1994.
6. Orphan Drug Act–1992.
7. Osteoporosis–1994.
8. Osteoporosis–1995-1996.
9. Parke-Davis–Federal Drug Supplier, 1991-1992.
10. Pfizer, Incorporated–1993.
11. Pharmaceutical Access and Prudent Purchasing Act (PAPPA)–1990 (1 of 7).
12. PAPPA–1990 (2 of 7).
13. PAPPA–1990 (3 of 7).
14. PAPPA–1990 (4 of 7).
15. PAPPA–1990 (5 of 7).
16. PAPPA–1990 (6 of 7).
17. PAPPA–1990 (7 of 7).
18. Pharmaceutical Companies–Price Restrain Commitment, 1993.
19. Pharmaceutical Indigent Drug Assistance Program–1992-1994.
20. Pharmaceutical Industry–1989-1996.
21. Pharmaceutical Industry Washington Advisory Committee–1987.
22. Pharmaceutical Issues–Briefing Book, 1994.
23. Pharmaceutical Issues–Clippings, 1989-1990.
24. Pharmaceutical Issues–Clippings, 1991-1996.
25. Pharmaceutical Manufacturers–1989-1996.
26. Pharmaceutical Manufacturers–Correspondence, 1988-1994.
27. Pharmaceutical Manufacturers Association (PMA)–1992.
28. PMA–Voluntary Agreement, 1993 (1 of 2).
29. PMA–Voluntary Agreement, 1993 (2 of 2).
30. Pharmaceutical Marketplace Reform–1993 (1 of 2).
31. Pharmaceutical Marketplace Reform–1993 (2 of 2).

Box 222 Pharmaceutical Industry and Drug Issues

1. Pharmaceutical Marketplace Reform–1993, November Hearing (1 of 4).
2. Pharmaceutical Marketplace Reform–1993, November Hearing (2 of 4).
3. Pharmaceutical Marketplace Reform–1993, November Hearing (3 of 4).
4. Pharmaceutical Marketplace Reform–1993, November Hearing (4 of 4).
5. Pharmaceutical Marketplace Reform Act–1994 (1 of 4).
6. Pharmaceutical Marketplace Reform Act–1994 (2 of 4).
7. Pharmaceutical Marketplace Reform Act–1994 (3 of 4).
8. Pharmaceutical Marketplace Reform Act–1994 (4 of 4).

Pharmaceutical Patents

9. 1992-1993.
10. General Agreements on Tariffs and Trade (GATT), 1995-1996 (1 of 11).
11. GATT, 1995-1996 (2 of 11).
12. GATT, 1995-1996 (3 of 11).
13. GATT, 1995-1996 (4 of 11).
14. GATT, 1995-1996 (5 of 11).
15. GATT, 1995-1996 (6 of 11).
16. GATT, 1995-1996 (7 of 11).
17. GATT, 1995-1996 (8 of 11).
18. GATT, 1995-1996 (9 of 11).
19. GATT, 1995-1996 (10 of 11).
20. GATT, 1995-1996 (11 of 11).
21. GATT, Briefing Book (1 of 2).
22. GATT, Briefing Book (2 of 2).
23. GATT, Charts.
24. GATT, Clippings (1 of 6).
25. GATT, Clippings (2 of 6).

Box 223 Pharmaceutical Industry and Drug Issues

Pharmaceutical Patents

1. General Agreements on Tariffs and Trade (GATT), Clippings (3 of 6).
2. GATT, Clippings (4 of 6).
3. GATT, Clippings (5 of 6).
4. GATT, Clippings (6 of 6).
5. GATT, Court Cases.
6. GATT, Food and Drug Administration (FDA) Ruling (1 of 2).
7. GATT, FDA Ruling (2 of 2).
8. GATT, Generic Drug Equity Coalition.
9. GATT, Glaxo Wellcome.
10. GATT, Hatch Amendment, 1995-1996 (1 of 3).
11. GATT, Hatch Amendment, 1995-1996 (2 of 3).
12. GATT, Hatch Amendment, 1995-1996 (3 of 3).
13. GATT, Hatch Substitute.
14. GATT, Hatch-Waxman Act, 1996 (1 of 2).
15. GATT, Hatch-Waxman Act, 1996 (2 of 2).
16. GATT, Judiciary Committee.
17. GATT, Judiciary Committee Hearing, February 1996 (1 of 5).
18. GATT, Judiciary Committee Hearing, February 1996 (2 of 5).
19. GATT, Judiciary Committee Hearing, February 1996 (3 of 5).
20. GATT, Judiciary Committee Hearing, February 1996 (4 of 5).
21. GATT, Judiciary Committee Hearing, February 1996 (5 of 5).
22. GATT, Legislation (1 of 3).
23. GATT, Legislation (2 of 3).
24. GATT, Legislation (3 of 3).
25. GATT, Letters of Support (1 of 3).
26. GATT, Letters of Support (2 of 3).
27. GATT, Letters of Support (3 of 3).
28. GATT, Medicare Hearing, February 1995.
29. GATT, Notes.

Box 224 Pharmaceutical Industry and Drug Issues

Pharmaceutical Patents

1. General Agreements on Tariffs and Trade (GATT), Opponents
2. GATT, Oversize Material (See Box 243).
3. GATT, Roll Call.
4. GATT, Specter "Compromise".
5. GATT, Talking Points (1 of 2).
6. GATT, Talking Points (2 of 2).

Pharmaceutical Industry and Drug Issues

7. Pharmacist Services, 1994.
8. Pharmacy Benefit Managers–Pharmacy Manufacturer Mergers, 1994-1995 (1 of 3).
9. Pharmacy Benefit Managers–Pharmacy Manufacturer Mergers, 1994-1995 (2 of 3).
10. Pharmacy Benefit Managers–Pharmacy Manufacturer Mergers, 1994-1995 (3 of 3).
11. Pharmacy Benefit Managers–Pharmacy Manufacturer Mergers, Merck-Medco 1993.
12. Pharmacy Benefit Managers–Pharmacy Manufacturer Mergers, 1994-1995 Oversized Materials (See Box 243).
13. Pharmacy Data–1991-1992.
14. Planned Parenthood–1994.
15. Poison Ivy Extract.
16. Premarin (Conjugated Estrogens)–1995-1996 (1 of 3).
17. Premarin (Conjugated Estrogens)–1995-1996 (2 of 3).
18. Premarin (Conjugated Estrogens)–1995-1996 (3 of 3).
19. Prescription Drug Consumer Protection Act–1993.
20. Prescription Drug Cost Containment Act–1991-1992 (1 of 8).
21. Prescription Drug Cost Containment Act–1991-1992 (2 of 8).
22. Prescription Drug Cost Containment Act–1991-1992 (3 of 8).
23. Prescription Drug Cost Containment Act–1991-1992 (4 of 8).
24. Prescription Drug Cost Containment Act–1991-1992 (5 of 8).
25. Prescription Drug Cost Containment Act–1991-1992 (6 of 8).
26. Prescription Drug Cost Containment Act–1991-1992 (7 of 8).
27. Prescription Drug Cost Containment Act–1991-1992 (8 of 8).
28. Prescription Drug Pricing Notebook–1989-1993 (1 of 3).
29. Prescription Drug Pricing Notebook–1989-1993 (2 of 3).
30. Prescription Drug Pricing Notebook–1989-1993 (3 of 3).
31. Prescription Drug Pricing Notebook–Indexed Letters.
32. Prescription Drug Pricing Notebook–News Articles (With Index).

Box 225 Pharmaceutical Industry and Drug Issues

1. Prescription Drug Pricing Notebook–Unindexed Letters and Other Materials.
2. Prescription Drug Programs for Older Americans–1992-1993.
3. Prescription Drugs–1990, Kennedy Hearings.
4. Prescription Drugs–1991-1992, S. 2000.
5. Prescription Drugs–1992, S. 2000 (1 of 2).
6. Prescription Drugs–1992, S. 2000 (2 of 2).
7. Prescription Drugs–Correspondence, 1992-1994 (1 of 4).
8. Prescription Drugs–Correspondence, 1992-1994 (2 of 4).
9. Prescription Drugs–Correspondence, 1992-1994 (3 of 4).
10. Prescription Drugs–Correspondence, 1992-1994 (4 of 4).
11. Prescription Drugs–Hearing, September 1990.
12. Prescription Drugs–Hearing, April 1991.
13. Prescription Drugs–Indigent Programs, 1992-1994.
14. Prescription Drugs–Seniors, Hearing, August 1987.
15. Prescription Drugs–Seniors, 1994 (1 of 2).
16. Prescription Drugs–Seniors, 1994 (2 of 2).
17. Prescription Drugs–Tax Credit, 1992-1995 (1 of 2).
18. Prescription Drugs–Tax Credit, 1992-1995 (2 of 2).
19. Product Liability–1992-1995 (1 of 3).
20. Product Liability–1992-1995 (2 of 3).
21. Product Liability–1992-1995 (3 of 3).
22. Product Liability–1994-1995, Biomaterials.
23. Product Liability–1995 (1 of 3).
24. Product Liability–1995 (2 of 3).
25. Product Liability–1995 (3 of 3).
26. David Pryor (DP)–Prescription Drug Activities, 1993 (1 of 5).
27. DP–Prescription Drug Activities, 1993 (2 of 5).

Box 226 Pharmaceutical Industry and Drug Issues

1. David Pryor (DP)–Prescription Drug Activities, 1993 (3 of 5).
2. DP–Prescription Drug Activities, 1993 (4 of 5).
3. DP–Prescription Drug Activities, 1993 (5 of 5).
4. DP–Prescription Drug Activities, 1994.
5. DP–Prescription Drug Activities, January 1994, Press Conference.
6. DP–Speeches, Statements, and Essays, 1991-1993.
7. DP–Trip, Arkansas, Sep 1987.
8. DP–Trip, Nevada, Feb 1994.

Puerto Rico–Drug Manufacturers and Federal Tax Credits

9. 1991 (1 of 2).
10. 1991 (2 of 2).
11. 1992 (1 of 2).
12. 1992 (2 of 2).
13. 1993 (1 of 2).
14. 1993 (2 of 2).
15. 1994-1995.
16. n.d. (1 of 2).
17. n.d. (2 of 2).
18. Clippings, 1985, 1991-1995.
19. Correspondence, 1989, 1991.
20. Correspondence, Jan-Mar 1992.
21. Correspondence, Apr 1992-Feb 1993.
22. Correspondence, Mar 1993.
23. Correspondence, Apr-Jul 1993.
24. Hearing, November 1989, Puerto Rico's Political Status.
25. Hearing, April 1993, Section 936 (1 of 2).
26. Hearing, April 1993, Section 936 (2 of 2).
27. Brian Irving, 1995.
28. Pharmaceutical Manufacturers Association, 1989-1992.
29. Possessions Wage Credit Act, 1993.
30. Press Releases, 1991-1993.
31. David Pryor, Statements and Speeches, 1992-1993.
32. Puerto Rican Statehood, 1990 (1 of 2).
33. Puerto Rican Statehood, 1990 (2 of 2).
34. Runaway Plants, 1990.

Box 227 Pharmaceutical Industry and Drug Issues

Puerto Rico–Drug Manufacturers and Federal Tax Credits

1. Runaway Plants, 1991.

Pharmaceutical Industry and Drug Issues

2. Pulmozyme–1993.
3. Schering Labs–Plough Foundation, 1992-1993.
4. Schering Labs–Proventil Inhalation Aerosol, 1993-1994.
5. Seminars–1993.
6. Seminars–1993, #1.
7. Seminars–1993, #2.
8. Seminars–1993, #5.
9. Senate Committee on Finance–Hearing, Prescription Drugs, April 1994.
10. Shiley, Incorporated–Heart Valves, 1994.
11. Tamoxifen Citrate–1994.
12. Vaccines–1991-1993 (1 of 2).
13. Vaccines–1991-1993 (2 of 2).
14. Vaccines–1993 (1 of 4).
15. Vaccines–1993 (2 of 4).
16. Vaccines–1993 (3 of 4).
17. Vaccines–1993 (4 of 4).
18. Vaccines–1993, Comprehensive Child Immunization Act (1 of 2).
19. Vaccines–1993, Comprehensive Child Immunization Act (2 of 2).
20. Vaccines–1993, Oversized Materials (See Box 243).
21. Vaccines–1993-1995 (1 of 2).
22. Vaccines–1993-1995 (2 of 2).
23. Vaccines–Schaus Case (DPT), 1993-1996 (1 of 2).
24. Vaccines–Schaus Case (DPT), 1993-1996 (2 of 2).
25. Veterans Health Care Act–1992.
26. Vitamins–1994.
27. Women and Children Rebates–1994.
28. Women and Children Rebates–1995-1996 (1 of 2).
29. Women and Children Rebates–1995-1996 (2 of 2).
30. World Health Organization–1992.
31. Zantac–1995.

Subseries 4. Chronological Files and Library Item Encyclopedias

The "Chronological Files" include correspondence and reports arranged by date. The "Library Item Encyclopedias" are collections of form letters addressing aging and health issues sent in reply to constituent inquiries.

Box 227 (cont.) Chronological Files and Library Item Encyclopedias

32. Jan-Feb 1989.
33. Mar 1989.
34. Apr 1989.
35. May 1989.
36. Jun 1989 (1 of 2).
37. Jun 1989 (2 of 2).
38. Jul 1989.
39. Aug 1989.

Box 228 Chronological Files and Library Item Encyclopedias

1. Sep 1989.
2. Oct 1989.
3. Nov 1989.
4. Dec 1989.
5. Jan 1990.
6. Feb 1990.
7. Mar 1990.
8. Apr 1990.
9. May 1990.
10. Jun 1990.
11. Jul 1990.
12. Aug 1990.
13. Sep-Oct 1990.
14. Nov-Dec 1990.
15. Jan 1991.
16. Feb 1991.
17. Mar 1991.
18. Apr 1991.
19. Jun 1991.
20. Jul 1991.

Box 229 Chronological Files and Library Item Encyclopedias

1. Aug 1991.
2. Sep 1991.
3. Oct-Dec 1991.
4. Jan 1992.
5. Feb 1992.
6. Mar 1992.
7. Apr 1992.
8. May-Jun 1992.
9. Jul 1992.
10. Aug-Sep 1992.
11. Oct-Dec 1992.
12. Jan-Jun 1993.
13. Jul-Dec 1993.
14. 1994.
15. Library Item Encyclopedia 1995.
16. Library Item Encyclopedia 1996.

Subseries 5. Correspondence–Restricted (may NOT be accessed)

Materials in this subseries are restricted as per donor agreement. They include correspondence related to aging and health issues for the periods 1989-1991 and 1993-1996. Correspondence with two sets of numbers preceding the date are items that apparently were microfilmed, but no copy of the microfilm was included with Senator Pryor's donated papers. Microfilmed correspondence include Aging Committee "cartridges" 76-107; these have been reassigned reel numbers. Restricted materials may NOT be accessed.

Box 230 Correspondence (Restricted materials; may NOT be accessed) 24 files

Box 231 Correspondence (Restricted materials; may NOT be accessed) 22 files

Box 232 Correspondence (Restricted materials; may NOT be accessed) 30 files

Box 233 Correspondence (Restricted materials; may NOT be accessed) 22 files

Box 234 Correspondence (Restricted materials; may NOT be accessed) 18 files

Box 235 Correspondence (Restricted materials; may NOT be accessed) 23 files

Box 236 Correspondence (Restricted materials; may NOT be accessed) 20 files

Box 237 Correspondence (Restricted materials; may NOT be accessed) 23 files

Box 238 Correspondence (Restricted materials; may NOT be accessed) 23 files

Box 239 Correspondence (Restricted materials; may NOT be accessed) 19 files

Box 240 Correspondence (Restricted materials; may NOT be accessed) 26 files

Box 241 Correspondence (Restricted materials; may NOT be accessed) 25 files

Box 242 Correspondence (Restricted materials; may NOT be accessed) 23 files

Microfilmed Correspondence (Restricted materials; may NOT be accessed) Microfilm reels 524-555

Subseries 6. Oversize Materials (Unrestricted)

This subseries includes oversize materials from the previous subseries.

Box 243 Subseries 1.
1. Fraud–Deceptive Mailings, 1993.
2. Fraud–Bank Sales of Uninsured Product, 1994-1995, Miscellaneous Materials.
3. Mental Health Working Group–1994.
4. Nursing Homes–Board and Care Hearing, 1989.
5. Nursing Homes–1991, Chemical Restraints.
6. Nursing Homes–1995.
7. Nursing Homes–Inspections.

Subseries 2.

8. Long Term Care–1991.
9. Long Term Care–Oversize Materials.
10. Medicare–Part B, Balance Billing Limits.
11. Medicare Catastrophic Coverage Act–1987-1988.
12. Older Americans Reauthorization Amendments Act–1991.
13. Retirement Equity Act–1984-1986.
14. Social Security Act Amendments–1994.
15. Social Security Reform–1996.
16. Social Security–SSI, 1994-1995.
17. Social Security–SSI, 1995, Hearing.
18. State Health Care–1992, Minnesota..

Subseries 3.

19. Clinton Administration–Health Care Reform Plan, 1992-1994.
20. Drug Issues–1994.
21. NIH–Drug Fair Price Act, 1993-1994.
22. Pharmaceutical Patents–GATT.
23. Pharmacy Benefit Managers–Pharmacy Manufacturer Mergers, 1994-1995.
24. Vaccines–1993.

Return to "Contents of Collection"	Last modified: Wednesday, December 20, 2006
Return to Special Collections Home Page
Return to University of Arkansas Libraries Home Page